Life Science Ecosystem to Gather in Marseilles for BioFIT

Life Science Ecosystem to Gather in Marseilles for BioFIT

For its eighth edition which will be taking place on December 10th and 11th, 2019 in Marseilles (France), BioFIT will be welcoming more than 1,300 participants from 35+ countries, over 80 international speakers and hosting 5 events. On the agenda: conferences and roundtables discussions, one-to-one meetings, pitch sessions, Would-be CEO session and exhibition.

Marseilles, one of the best innovative hubs for Biotech in Europe

It is in Marseilles, in an exceptional Life Sciences ecosystem at the heart of the Sud Provence-Alpes-Côte d’Azur region, where the eighth edition of BioFIT, the leading European event for early-stage deals and investment rounds in the Life Sciences field, will be held. The Sud Provence-Alpes-Côte d’Azur region is the second largest French centre for public scientific health research and the second French region for patent applications and clinical trials. It is also one of the most concentrated hospital networks in France with a vast array of research platform and one of the most dynamic clinical, industrial and academic research activities in France. The region’s research laboratories stand out in immune-oncology with the Marseille Immunopole cluster, infectious and tropical diseases and clinical microbiology hosted by the Hospital-University Institute (IHU) and rare and orphan diseases and neurosciences.

BioFIT, the meeting place for early-stage deals and investment rounds

Since its first edition, in 2010, BioFIT has emerged as the leading partnering event in Europe to source early-stage deals innovations and collaborative research capacities in Life Sciences, and also to obtain funding to seed rounds. In response to Biotech and Life Sciences challenges of our society, the challenge is to promote and accelerate R&D and innovation partnering opportunities. During two days, TTOs, research institutes, academics, pharma and diagnostic companies, emerging biotech companies, preclinical CROs and CDMOs, pre-seed, seed and Series A investors, professional services, consulting and law firms, will meet to develop tomorrow’s innovative products. BioFIT highlights the expertise of key actors of the sector, promotes innovation and their funding and leads to partnerships opportunities.

A conference programme that aims to widen the scope of the topics discussed

For this 2019 edition and steered by a prestigious Committee, the BioFIT conference programme brings together bright minds to debate on innovation-focused topics, to foster learning inspiration and wonder, and provoke conversations that matter. The conference programme deals with the academia-industry collaborations, investment trends, pre-seed, seed and Series A in the field of Life Sciences.

This year, the plenary session will wonder “What is pharma looking for nowadays?”, focusing on collaboration and licensing opportunities pharma is looking for, while changing from a drug developer to a healthcare solution provider. It aims at understanding pharma’s view point, the consequences for the orientation deals, the way it is going to influence the relationships with academia and biotech start-ups. Also, the One Health concept will be exploring through two conferences about animal healthcare solutions and animal health industry.

More than 80 international experts from research, industry and investment worlds, will share their vision and experience around these topics. Among them: Tim Haines (Abingworth, UK), Cheryl Zimberlin (M Ventures, NL), Rémi Droller (Kurma Partners, FR), Sasha Bucher (Roivant Sciences, USA), Joao Ribas (Novo Seeds, DK), Cyril Teixeira Da Silva (European Investment Bank, LU), Sylvain Sachot (Asabys Partner, ES) and many others.

 

2 days around multiple activities to foster partnerships

ONE-TO-ONE MEETINGS: Participants can pre-schedule one-to-one meetings with the most qualified players in the sector and identify potential project partners.

CONFERENCES AND ROUNDTABLE DISCUSSIONS: BioFIT offers a broad programme of specialised conferences to be in the heart of Life Sciences innovation.

WOULD-BE CEO SESSION: Dedicated to any bioentrepreneur looking for a project to get involved in and any projects needing a CEO to lead it.

PITCH SESSIONS: To detect the most innovative and promising start-ups, R&D projects, collaborative and licensing opportunities and services.

EXHIBITION: Ideally located at the focal point of the event, the exhibition area is the perfect place to exchange with key players of the sector.

 

They confirmed their presence

Participate at BioFIT is a unique opportunity to meet major international companies of the sector. They will be there: PFIZER, SANOFI, GENFIT, MSD, ALMIRALL, BAYER, BOEHRINGER INGELHEIM, EVOTEC, IPSEN, NOVO NORDISK, ROCHE, LFB, ADVENT FRANCE BIOTECHNOLOGY, INNATE PHARMA, ONTOFORCE…